Professional Documents
Culture Documents
Vyvanseisnot
forweightloss.ItisnotknownifVyvanseissafeandeffectiveforthetreatmentofobesity.
IMPORTANTSAFETYINFORMATION
Vyvanseisafederallycontrolledsubstance(CII)becauseitcanbeabusedorleadto
dependence.KeepVyvanseinasafeplacetopreventmisuseandabuse.Sellingorgivingaway
Vyvansemayharmothers,andisagainstthelaw.SAFETYINFORMATIONCONTINUEDBELOW
Paynomorethan$30forupto12prescriptions
uptoamaximumsavingsof$60per
prescription.*
NowyoucaninstantlysaveonyourVyvanseprescriptionwiththeVyvansePrescriptionSavingsOffer.Followthese
stepstostartsaving:
PrinttheVyvansePrescriptionSavingsOffernow(orwaitforitinyouremail).Youcanalsoopttoshow
ittothepharmacistusingawirelessdevice.
TaketheVyvanseprescriptionandtheVyvansePrescriptionSavingsOffertothepharmacy.
KeeptheVyvansePrescriptionSavingsOfferinasafeplaceandbringittothepharmacyeachtimethe
prescriptionisfilled.
Thanksforregistering.
*Paynomorethan$30perprescriptionofVyvanse(lisdexamfetaminedimesylate)foramaximumofupto$60
savingsperprescription.Theoffercoverstheamountabove$30uptoamaximumof$60savingsperprescription.
Youwillberesponsibleforanyadditionalcostabove$90foreachprescription.Thisofferisgoodforamaximumof
12prescriptionfillsanduptoatotalsavingsof$720.Offerexpires.Restrictionsmayapply.
5/31/2017
Pleaseseeimportantsafetyinformationonpage3andclickhereforPrescribingInformationandsee
accompanyingMedicationGuideanddiscusswithyourdoctor.
BIN#:
PCN#:
GRP#:
004682
CN
EC31001355 ID#:
08889442883
5/31/2017
Expirationdate:
Limitoneofferperpatient.Maximum30capsulesperoffer.*Restrictionsmayapply.
TermsandConditionsforPayNoMoreThan$30SavingsOffer
Eligiblepatientswillpayaminimumof$30andreceiveuptoamaximumof$60offtheircopayoroutofpocket
expenseforupto30capsulesofVyvanse(lisdexamfetaminedimesylate).Offerisvalidforupto12usesthrough
offerexpiry.Thepatientmaysaveupto$720acrossall12uses.AvalidPrescriberID#isrequiredoneach
prescription.
PatientInstructions:Offerisvalidforcopayoroutofpocketexpensesthataregreaterthan$30.Ifyour
prescriptionexpenseislessthanorequalto$30,thennodiscountisapplied.Ifyourprescriptionexpenseis
greaterthan$30andlessthanorequalto$90,thenyouonlypay$30.Ifyourprescriptionexpenseexceeds$90,
thenyouareresponsibleforanyremainingbalance.Inordertoredeemthisoffer,youmusthaveavalid
prescriptionforVyvanse.Followthedosageinstructionsgivenbytheprescriber.Thisoffermaynotberedeemed
forcash.Byusingthisoffer,youarecertifyingthatyoumeettheeligibilitycriteriaandwillcomplywiththeterms
andconditionssetforthintheRestrictionssectionbelow.Patientswithquestionsaboutthisoffershouldcall
18664413469.
Pharmacist:Whenyouapplythisoffer,youarecertifyingthatyouarenotsubmittingtheclaimforthisprescription
forreimbursementunderanyfederal,state,orothergovernmentalprogram.Participationinthisoffermustcomply
withallapplicablelawsandregulationsasapharmacyprovider.Byparticipatinginthisoffer,youarecertifyingthat
youwillcomplywiththetermsandconditionssetforthintheRestrictionssectionbelow.
PharmacistinstructionsforapatientpayingwithaneligibleThirdPartyPayer:Submittheclaimtotheprimary
ThirdPartyPayerfirst,andthensubmitthebalanceduetoTherapyFirstPlusasaSecondaryPayerCOB
(coordinationofbenefits)withpatientresponsibilityamountandavalidOtherCoverageCode,(e.g.,8).The
patientisresponsibleforthefirst$30andtheofferpaysuptothenext$60.Reimbursementwillbereceivedfrom
TherapyFirstPlus.
Pharmacistinstructionsforacashpayingpatient:SubmitthisclaimtoTherapyFirstPlus.AvalidOther
CoverageCode(e.g.,1)isrequired.Thepatientisresponsibleforthefirst$30andtheofferpaysuptothenext
$60.ReimbursementwillbereceivedfromTherapyFirstPlus.
ValidOtherCoverageCoderequired.ForanyquestionsregardingTherapyFirstPlusonlineprocessing,please
calltheHelpDeskat18004225604.
Restrictions:ThisofferisvalidintheUnitedStates.Offernotvalidforprescriptionscoveredbyorsubmittedfor
reimbursementunderMedicaid,aMedicaredrugbenefitplan,Tricare,orotherfederalorstatehealthprograms
(includinganystatemedicalassistanceprogram).Ifthepatientiseligibleforprescriptiondrugbenefitsunderany
suchprogram,thepatientcannotusethisoffer.Byusingthisoffer,thepatientcertifiesthatheorshewillcomply
withanytermsofhisorherhealthinsurancecontractrequiringnotificationtohisorherpayeroftheexistence
and/orvalueofthisoffer.Itisillegalto(orofferto)sell,purchase,ortradethisoffer.Thisofferisnottransferable
andislimitedtooneofferperperson.Offerexpires.
5/31/2017
Thisofferisnotvalidifreproduced.Voidwhereprohibitedbylaw.OfferprogrammanagedbyPSKW,LLCon
behalfofShireUSInc.Thepartiesreservetherighttorescind,revoke,oramendthisofferwithoutnoticeatany
time.
Pleaseseeimportantsafetyinformationonpage3andclickhereforPrescribingInformationandsee
accompanyingMedicationGuideanddiscusswithyourdoctor.
IMPORTANTSAFETYINFORMATION
Vyvanseisafederallycontrolledsubstance(CII)becauseitcanbeabusedorleadtodependence.Keep
Vyvanseinasafeplacetopreventmisuseandabuse.SellingorgivingawayVyvansemayharmothers,andis
againstthelaw.
Vyvanseisastimulantmedicine.Tellthedoctorifyouoryourchildhaveeverabusedorbeendependentonalcohol,
prescriptionmedicines,orstreetdrugs.
WhoshouldnottakeVyvanse?
DonottakeVyvanseifyouoryourchildis:
takingorhastakenanantidepressionmedicinecalledamonoamineoxidaseinhibitor(MAOI)withinthepast14
days.
sensitiveorallergicto,orhadareactiontootherstimulantmedicines.
ProblemsthatcanoccurwhiletakingVyvanse.Tellthedoctor:
ifyouoryourchildhaveheartproblemsorheartdefects,highbloodpressure,orafamilyhistoryofthese
problems.Thisisimportantbecausesuddendeathhasoccurredinpeoplewithheartproblemsordefects,and
suddendeath,strokeandheartattackhavehappenedinadults.Sinceincreasesinbloodpressureandheart
ratemayoccur,thedoctorshouldregularlychecktheseduringtreatment.Callthedoctorrightawayifyouor
yourchildhaveanysignsofheartproblemssuchaschestpain,shortnessofbreath,orfaintingwhiletaking
Vyvanse.
ifyouoryourchildhavementalproblems,orafamilyhistoryofsuicide,bipolarillness,ordepression.Thisis
importantbecauseneworworseningbehaviorandthoughtproblemsorbipolarillnessmayoccur.New
symptomssuchasseeingorhearingthingsthatarenotreal,believingthingsthatarenottrue,beingsuspicious,
orhavingnewmanicsymptomsmayoccur.Callthedoctorrightawayifthereareanyneworworsening
mentalsymptomsduringtreatment.
ifyouoryourchildhavecirculationproblemsinfingersandtoes(peripheralvasculopathy,includingRaynauds
phenomenon).Fingersortoesmayfeelnumb,cool,painful,sensitivetotemperatureand/orchangecolorfrom
pale,toblue,tored.Callthedoctorrightawayifanysignsofunexplainedwoundsappearonfingersortoes
whiletakingVyvanse.
ifyourchildishavingslowingofgrowth(heightandweight)Vyvansemaycausethisserioussideeffect.Your
childshouldhavehisorherheightandweightcheckedoftenwhiletakingVyvanse.Thedoctormaystop
treatmentifaproblemisfoundduringthesecheckups.
ifyouoryourchildarepregnant,breastfeeding,orplantobecomepregnantorbreastfeed.
WhatarepossiblesideeffectsofVyvanse?
ThemostcommonsideeffectsofVyvansereportedinADHDstudiesinclude:
anxiety
drymouth
decreasedappetite
irritability
diarrhea
lossofappetite
dizziness
nausea
troublesleeping
upperstomachpain
vomiting
weightloss
ThemostcommonsideeffectsofVyvansereportedinstudiesofadultswithmoderatetosevereB.E.D.include:
drymouth
increasedheartrate
anxiety
troublesleeping
constipation
decreasedappetite
feelingjittery
WhatisVyvanse?
Vyvanse(lisdexamfetaminedimesylate)isaprescriptionmedicineusedforthetreatmentofAttention
Deficit/HyperactivityDisorder(ADHD)inpatients6yearsandabove,andforthetreatmentofmoderatetoseverebinge
eatingdisorder(B.E.D.)inadults.Vyvanseisnotforweightloss.ItisnotknownifVyvanseissafeandeffectiveforthe
treatmentofobesity.
Foradditionalsafetyinformation,clickhereforPrescribingInformationandMedicationGuideanddiscusswith
yourdoctor.
YouareencouragedtoreportnegativesideeffectsofprescriptiondrugstotheFDA.Visitwww.fda.gov/medwatch,
orcall1800FDA1088.
VyvanseisaregisteredtrademarkofShireLLC.
2016P.S.K.W.Associates,PatentPending
2016ShireUSInc.,Lexington,MA02421.Allrightsreserved.
S1313707/16
MEDICATION GUIDE
VYVANSE [V - vns]